Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-052980
Filing Date
2023-04-28
Accepted
2023-04-28 16:15:46
Documents
4
Period of Report
2023-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm232136d1_def14a.htm DEF 14A 454643
2 GRAPHIC tm232136d1_def14aimg001.jpg GRAPHIC 1529
3 GRAPHIC tm232136d1_def14aimg002.jpg GRAPHIC 125061
4 GRAPHIC tm232136d1_def14aimg003.jpg GRAPHIC 109854
  Complete submission text file 0001104659-23-052980.txt   781875
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36598 | Film No.: 23866423
SIC: 2834 Pharmaceutical Preparations